ERBB2 and neoplasm: The ERBB2 gene study was implementing the status of 17q21 amplicon containing TOP2A. An immunohistochemical analysis helped us to understand the tumor protein expression of topoisomerase IIα combined with erbB2 and p53 immunohistochemistry.